Upon in vitro CD3-induced reactivation, CD4+ T cells from MS patients expressed more CD40L and produced increased levels of inflammatory mediators, compared to T cells from healthy controls, suggesting that CD40L is especially expressed by activated proinflammatory T cells (79). This evidence concerns the gene CD4 and myeloid sarcoma.